Abstract
A new β-carboline-type alkaloidal glycoside, glucodichotomine B, four new neolignan glycosides, dichotomosides A, B, C, and D, and a new phenylpropanoid glycoside, dichotomoside E, were isolated from a Chinese natural medicine, the roots of Stellaria dichotoma L. var. lanceolata. The structures of the new glycosides were determined on the basis of chemical and physicochemical evidence. Among them, dichotomoside D inhibited the release of β-hexosaminidase (IC50=64 μM) as well as tumor necrosis factor-α and interleukin-4 (IC50=16, 34 μM) in RBL-2H3 cells. These findings suggest that dichotomoside D is more effective against the late-phase reactions in type I allergy than in the immediate phase. © 2004 Pharmaceutical Society of Japan.
Author supplied keywords
Cite
CITATION STYLE
Morikawa, T., Sun, B., Matsuda, H., Wu, L. J., Harima, S., & Yoshikawa, M. (2004). Bioactive constituents from Chinese natural medicines. XIV.1 new glycosides of β-carboline-type alkaloid, neolignan, and phenylpropanoid from Stellaria dichotoma L. var. lanceolata and their antiallergic activities. Chemical and Pharmaceutical Bulletin, 52(10), 1194–1199. https://doi.org/10.1248/cpb.52.1194
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.